Positive study data from Zosano Pharma's ZP-PTH transdermal patch for treating osteoporosis
Links shared publicly online about this topic.
- 1,615total visits
Positive study data from Zosano Pharma's ZP-PTH transdermal patch for treating osteoporosis
Zosano Pharma, Inc., a privately held pharmaceutical company developing products using a novel transdermal delivery technology, announced publication in the current issue of the Journal of Clinical Endocrinology and Metabolism of results from a positive phase 2 study of its rapid-delivery transdermal patch (ZP-PTH) for the treatment of postmenopausal osteoporosis.
View full resource at news-medical.net
Tags: Endocrinology, Osteoporosis, Pharma, Phase 2 Clinical Trial, News
Most Recently Shared on November 9, 2009 at 5:25 pm By:
Osteoporosis News: Positive study data from Zosano Pharma's ZP-PTH transdermal patch for trea.. http://bit.ly/2y5a3L
Advertisement
